However, a number of trials have demonstrated that greater improvements in FBG and/or HbA1c can be achieved with insulin glargine vs. NPH insulin, with a lower risk of hypoglycaemia, even with intensive insulin titration regimens (13,14,17). This evidence concerns the gene INS and Hypoglycemia.